Medifast Inc logo

MED

Medifast Inc

$141.68

Earnings Summary

Revenue
$453.33Mn
Net Profits
$39.11Mn
Net Profit Margins
8.63%
PE Ratio
10.6

Highlights

Revenue:

Medifast Inc’s revenue jumped 15% since last year same period to $453.33Mn in the Q2 2022. On a quarterly growth basis, Medifast Inc has generated 8.56% jump in its revenue since last 3-months.

Net Profits:

Medifast Inc’s net profit fell -16.72% since last year same period to $39.11Mn in the Q2 2022. On a quarterly growth basis, Medifast Inc has generated -6.39% fall in its net profits since last 3-months.

Net Profit Margins:

Medifast Inc’s net profit margin fell -27.58% since last year same period to 8.63% in the Q2 2022. On a quarterly growth basis, Medifast Inc has generated -13.76% fall in its net profit margins since last 3-months.

PE Ratio:

Medifast Inc’s price-to-earnings ratio after this Q2 2022 earnings stands at 10.6.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Medifast Inc post its latest quarter earnings

EPS Estimate Current Quarter
3.23
EPS Estimate Current Year
3.23

Highlights

EPS Estimate Current Quarter:

Medifast Inc’s earning per share (EPS) estimates for the current quarter stand at 3.23 - a -9.52% fall from last quarter’s estimates.

EPS Estimate Current Year:

Medifast Inc’s earning per share (EPS) estimates for the current year stand at 3.23.

Key Ratios

Key ratios of the Medifast Inc post its Q2 2022 earnings

Earning Per Share (EPS)
3.42
Return on Assets (ROA)
0.37
Return on Equity (ROE)
0.97
Dividend Per Share (DPS)
6.12

Highlights

Earning Per Share (EPS):

Medifast Inc’s earning per share (EPS) fell -13.64% since last year same period to 3.42 in the Q2 2022. This indicates that the Medifast Inc has generated -13.64% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Medifast Inc’s return on assets (ROA) stands at 0.37.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Medifast Inc’s return on equity (ROE) stands at 0.97.

Dividend Per Share (DPS):

Medifast Inc declared 6.12 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-03
3.23
3.42
5.88%
2022-05-02
3.57
3.59
0.56%

Company Information

Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a Community to help Clients achieve Lifelong Transformation, One Healthy Habit at a Time®. Based on nearly 40 years of experience, Medifast has redefined direct selling by combining the best aspects of the model. Its community of thousands of independent OPTAVIA Coaches teach Clients how to develop holistic healthy habits through the proprietary Habits of Health® Transformational System. Medifast is ranked second on FORTUNE's 100 Fastest-Growing Companies list in 2020. The company was also named to Forbes' 100 Most Trustworthy Companies in America list in 2017.

Organisation
Medifast Inc
Headquarters
Owings Mills, Maryland, US
Employees
713
Industry
Retail Trade
CEO
Daniel Chard